After Covid, BioNTech Has Its Sights Set on Malaria

Motley Fool2021-07-27

BioNTech entered 2020 as a well-respected — if a bit under-the-radar — biotech company. A little more than a year later, the firm is world-famous for creating one of the most successful coronavirus ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

KVCGTan
2021-07-27
KVCGTan
Interesting. Like?
Lsn
2021-07-27
Lsn
Good 👍
- sarahlovesgh:
  Nice
PengsieX
2021-07-27
PengsieX
Please check on mRNA long term side effects first
虎视Tan
2021-07-27
虎视Tan
Good move why not set sight on dengue
XavierSee
2021-07-27
XavierSee
Nice
Archiparia
2021-07-27
Archiparia
I think biontech stock will rise a lot

发表看法

104

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1153403036?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-07-27 11:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153403036","market":"us","top_or_hot":-1,"title":"After Covid, BioNTech Has Its Sights Set on Malaria","media":"Motley Fool","content":"<div>\n<p>BioNTech entered 2020 as a well-respected — if a bit under-the-radar — biotech company. A little more than a year later, the firm is world-famous for creating one of the most successful coronavirus ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/26/after-covid-biontech-has-its-sights-set-on-malaria/\">网页链接</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After Covid, BioNTech Has Its Sights Set on Malaria</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter Covid, BioNTech Has Its Sights Set on Malaria\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 11:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/26/after-covid-biontech-has-its-sights-set-on-malaria/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BioNTech entered 2020 as a well-respected — if a bit under-the-radar — biotech company. A little more than a year later, the firm is world-famous for creating one of the most successful coronavirus ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/26/after-covid-biontech-has-its-sights-set-on-malaria/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BNTX","symbol_name":"BioNTech SE","start_time":0,"source_url":"https://www.fool.com/investing/2021/07/26/after-covid-biontech-has-its-sights-set-on-malaria/","article_id":"1153403036","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153403036","pubTimestamp":1627356038,"columns":[],"sourceInfo":null,"weMediaInfo":null,"summary":"BioNTech entered 2020 as a well-respected — if a bit under-the-radar — biotech company. A little mor","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BNTX":"BioNTech SE"},"translate_title":"在Covid之后，BioNTech将目光投向了疟疾","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":0.9},"content_text":"BioNTech entered 2020 as a well-respected — if a bit under-the-radar — biotech company. A little more than a year later, the firm is world-famous for creating one of the most successful coronavirus vaccines, its shares are up 150%, and co-founder Uğur Şahin is now one of the world's 500 richest people. Not too shabby.\nOn Monday, the company announced its next quest: a solo venture to develop a shot that will prevent malaria, one of the world's deadliest diseases and a notorious enigma for vaccine producers.\nThe Hardest Pathogen to Hack\nThere is currently only one approved malaria vaccine. Mosquirix, developed by GlaxoSmithKline, is only 39% effective over four years. Meanwhile, there were 229 million malaria cases in 2019 — 94% of them in Africa — and 400,000 people die from the disease every year, almost all of them African children.\nBioNTech will develop malaria vaccine candidates using messenger ribonucleic acid (mRNA), which directs the body to make parts of a virus to provoke an immune response. The firm will also produce and test other candidates at facilities in Africa:\n\nOne such candidate, the first shot to clear the World Health Organization's 75% efficacy target, was introduced this year by the University of Oxford. It prevented 77% of cases in a study of 450 children in Burkina Faso, and a 4,800-child trial to confirm the results is in the planning stages.\nBioNTech is aiming to have mRNA malaria and tuberculosis vaccines ready for clinical trials next year, but said malaria could prove as difficult to research as cancer. The company has benchmarked €20 million to €50 million for early stage development.\n\n\"This will not be a home run,\" Şahin told theFinancial Times. \"This is a pathogen which is really, really difficult to hack.\" Any malaria vaccine BioNTech develops will be sold in Africa on a non-profit basis, and the company is aiming for a shot that's 90% effective for one to two years.\nInvasive And Evasive:Malaria is caused by a complex parasite that can potentially make thousands of antigens and has many methods of evading the immune system. Unlike many diseases, it's possible to catch again and again due to its complexity.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":809683583,"gmtCreate":1627365544142,"gmtModify":1631892961244,"author":{"id":"3570938362108330","authorId":"3570938362108330","name":"KVCGTan","avatar":"https://static.tigerbbs.com/2126be6bc046089345232547cb51d38a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3570938362108330","authorIdStr":"3570938362108330"},"htmlText":"Interesting. Like?","listText":"Interesting. Like?","text":"Interesting. Like?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/809683583","repostId":1153403036,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":809698424,"gmtCreate":1627363186168,"gmtModify":1633765698311,"author":{"id":"3586853455165770","authorId":"3586853455165770","name":"Lsn","avatar":"https://static.tigerbbs.com/b2f8105b7bbd2252317e8eb58f208fc6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586853455165770","authorIdStr":"3586853455165770"},"htmlText":"Good 👍&nbsp;","listText":"Good 👍&nbsp;","text":"Good 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/809698424","repostId":1153403036,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5343270,"gmtCreate":1627363238954,"gmtModify":1635220503784,"authorId":3581734886041988,"author":{"id":3581734886041988,"idStr":"3581734886041988","authorId":3581734886041988,"name":"sarahlovesgh","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":809698424,"type":1,"supId":0,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"}],"langContent":"EN"},{"id":809690272,"gmtCreate":1627362822096,"gmtModify":1633765701214,"author":{"id":"3578047933589423","authorId":"3578047933589423","name":"PengsieX","avatar":"https://static.tigerbbs.com/ebe92821eba3b91a6431d698b66bbed5","vip":1,"hat":"https://static.tigerbbs.com/f84859c65fc2d7681e28f6b8e9b0535a","crmLevel":4,"crmLevelSwitch":0,"idStr":"3578047933589423","authorIdStr":"3578047933589423"},"htmlText":"Please check on mRNA long term side effects first","listText":"Please check on mRNA long term side effects first","text":"Please check on mRNA long term side effects first","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/809690272","repostId":1153403036,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":809609826,"gmtCreate":1627362099165,"gmtModify":1633765706091,"author":{"id":"3581738832645942","authorId":"3581738832645942","name":"虎视Tan","avatar":"https://static.tigerbbs.com/b8937bd48ee9805c92670bd1c3dd8e06","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3581738832645942","authorIdStr":"3581738832645942"},"htmlText":"Good move why not set sight on&nbsp;dengue","listText":"Good move why not set sight on&nbsp;dengue","text":"Good move why not set sight on dengue","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/809609826","repostId":1153403036,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":809600385,"gmtCreate":1627362014147,"gmtModify":1633765706881,"author":{"id":"3586581180889843","authorId":"3586581180889843","name":"XavierSee","avatar":"https://static.tigerbbs.com/eb0e623ff55f8e13ab98c063c20cfdb7","vip":1,"crmLevel":9,"crmLevelSwitch":0,"idStr":"3586581180889843","authorIdStr":"3586581180889843"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/809600385","repostId":1153403036,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":809875869,"gmtCreate":1627361799251,"gmtModify":1633765708613,"author":{"id":"3582928483660659","authorId":"3582928483660659","name":"Archiparia","avatar":"https://static.tigerbbs.com/f8cc7fc40996c719dfef5dc0edc1819b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582928483660659","authorIdStr":"3582928483660659"},"htmlText":"I think biontech stock will rise a lot","listText":"I think biontech stock will rise a lot","text":"I think biontech stock will rise a lot","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/809875869","repostId":1153403036,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":104,"commentSize":18,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1153403036"}